Isbn: 9780128039595 - drug design and discovery in alzheimer’s disease (10 Ergebnisse)

Paperback. Zustand: Brand New. 1st edition. 784 pages. 9.00x7.50x1.25 inches. In Stock.

Paperback. Zustand: new. Paperback. Drug Design and Discovery in Alzheimer's Disease Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Taschenbuch. Zustand: Neu. Drug Design and Discovery in Alzheimer's Disease | Atta-Ur Rahman (u. a.) | Taschenbuch | Englisch | 2015 | Elsevier Science | EAN 9780128039595 | Verantwortliche Person für die EU: Zeitfracht Medien GmbH, Ferdinand-Jühlke-Str. 7, 99095 Erfurt, produktsicherheit[at]zeitfracht[dot]de | Anbieter: preigu. …

Zustand: New. Editor(s): Atta-ur-Rahman; Choudhary, Muhammad. Num Pages: 784 pages. BIC Classification: PNF. Category: (P) Professional & Vocational. Dimension: 190 x 233 x 32. Weight in Grams: 1558. . 2015. 1st Edition. Paperback. . . . .

Zustand: New.

Paperback. Zustand: Brand New. 1st edition. 784 pages. 9.00x7.50x1.25 inches. In Stock.

Zustand: New. Editor(s): Atta-ur-Rahman; Choudhary, Muhammad. Num Pages: 784 pages. BIC Classification: PNF. Category: (P) Professional & Vocational. Dimension: 190 x 233 x 32. Weight in Grams: 1558. . 2015. 1st Edition. Paperback. . . . . Books ship from the US and Ireland.

Paperback. Zustand: new. Paperback. Drug Design and Discovery in Alzheimer's Disease Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Drug Design and Discovery in Alzheimer's Disease includes expert reviews of recent developments in Alzheimer's disease (AD) and neurodegenerative disease research. Originally published by Bentham as Frontiers in Drug Design and Discovery, Volume 6and now distributed by Elsevier, this compilation of the sixteen articles, written by leading global researchers, focuses on key developments in the understanding of the disease at molecular levels, identification and validation of molecular targets, as well as innovative approaches towards drug discovery, development, and delivery. Beginning with an overview of AD pharmacotherapy and existing blockbuster drugs, the reviews cover the potential of both natural and synthetic small molecules; the role of cholinesterases in the on-set and progression of AD and their inhibition; the role of beta-site APP clearing enzyme-1 (BACE-1) in the production of -amyloid proteins, one of the key reasons of the progression of AD; and other targets identified for AD drug discovery. 784 pp. Englisch.…

Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Drug Design and Discovery in Alzheimer's Disease includes expert reviews of recent developments in Alzheimer's disease (AD) and neurodegenerative disease research. Originally published by Bentham as Frontiers in Drug Design and Discovery, Volume 6and now distributed by Elsevier, this compilation of the sixteen articles, written by leading global researchers, focuses on key developments in the understanding of the disease at molecular levels, identification and validation of molecular targets, as well as innovative approaches towards drug discovery, development, and delivery. Beginning with an overview of AD pharmacotherapy and existing blockbuster drugs, the reviews cover the potential of both natural and synthetic small molecules; the role of cholinesterases in the on-set and progression of AD and their inhibition; the role of beta-site APP clearing enzyme-1 (BACE-1) in the production of -amyloid proteins, one of the key reasons of the progression of AD; and other targets identified for AD drug discovery.…